why choose us

First received: February 02, 2023

Clinical Trial: Empagliflozin in Patients With Cirrhosis and Ascites

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cirrhosis

Study Type: INTERVENTIONAL


Official Title: Effects of Empagliflozin on Natriuresis and Volume Overload in Patients With Cirrhosis and Ascites

Brief Summary: A proof-of-concept placebo-controlled trial to explore the acute and 14-day effects of empagliflozin on natriuresis and total body water in patients with cirrhosis and ascites.We will additionally investigate its effect on neurohumoral activation, and renal hemodynamics.

Read more